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Abstract 
Background: Models for predicting the outcome of patients hospitalized for heart failure (HF) 
rarely take a holistic view. We assessed the ability of measures of frailty and social support in 
addition to demographic, clinical, imaging and laboratory variables to predict short-term 
outcome for patients discharged after a hospitalization for HF. 
Methods: OPERA-HF is a prospective observational cohort, enrolling patients hospitalized for 
HF in a single center in Hull, UK. Variables were combined in a logistic regression model after 
multiple imputation of missing data to predict the composite outcome of death or readmission at 
30 days. Comparisons were made to a model using clinical variables alone. The discriminative 
performance of each model was internally validated with bootstrap re-sampling. 
Results: 1094 patients were included (mean age 77 [interquartile range 68 – 83] years; 40% 
women; 56% with moderate to severe left ventricular systolic dysfunction) of whom 213 (19%) 
had an unplanned re-admission and 60 (5%) died within 30 days. For the composite outcome, a 
model containing clinical variables alone had an area under the receiver-operating characteristic 
curve (AUC) of 0.68 [95% CI 0.64 – 0.72]. Adding marital status, support from family and 
measures of physical frailty increased the AUC (p<0.05) to 0.70 [95% CI 0.66 – 0.74].  
Conclusions: Measures of physical frailty and social support improve prediction of 30-day 
outcome after an admission for HF but predicting near-term events remains imperfect. Further 
external validation and improvement of the model is required.  
Keywords: heart failure, 30-day re-admission, mortality, frailty, psychosocial factors. 
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1. Introduction 
Patients with heart failure (HF) are often re-admitted to hospital shortly after discharge,1–
3 although only 15-30% of such events are due to worsening heart failure. Repeated admissions 
to hospital are associated with substantial impairment in a patient’s quality of life, high costs and 
increased mortality.4 Some re-admissions are potentially avoidable and preventing them may 
benefit both patients and the health-care system. Outcome may be partly determined by the 
severity of cardiac dysfunction, but physical frailty, co-morbidity, anxiety and depression, 
cognitive dysfunction and poor social support might also contribute. Focusing only on cardiac 
dysfunction may reduce the ability to predict adverse outcomes and miss opportunities to prevent 
them.  
Developing a holistic model that can predict which patients with HF are at high risk of 
early re-admission or death, and identify possible treatment targets, might improve management 
and reduce events. Currently there is no such model.5-6 Many predictive algorithms have been 
designed, but those aiming to predict short-term composite outcomes perform poorly compared 
to those designed to predict longer-term mortality.6-7  
The OPERA-HF study was designed to collect a broad range of information on physical 
frailty, mood, cognitive function and social support amongst patients admitted for the treatment 
of worsening HF to find out whether such measures improve prediction of outcome compared to 
conventional clinical variables alone. The current analysis focuses on 30-day outcomes. 
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2. Methods 
2.1. Study design 
OPERA-HF (An Observational registry to assess and PrEdict the in-patient course, risk 
of Re-Admission and mortality for patients hospitalised for or with Heart Failure) is a 
prospective observational study, enrolling consecutive, consenting patients hospitalized for HF in 
the Hull & East Yorkshire Hospitals NHS Trust, UK. The aim of the study is to create a holistic 
view of the patients, their general condition and co-morbidities, and to identify predictors of 
mortality and re-admission to hospital. Data were collected during hospital admission and just 
prior to discharge. The Charlson co-morbidity index (CCI) was used to assess co-morbidity.8 
Psycho-social information including depression and anxiety, cognitive function and social 
support was collected during hospitalization using questionnaires (see below for details).  
Patients had to fulfill the following criteria to be included: age >18 years; usual residence 
in the region served by the Hull & East Yorkshire Hospitals Trust; hospitalization for HF; 
treatment with loop diuretics; and at least one of the following criteria to confirm a diagnosis of 
HF: left ventricular ejection fraction (LVEF) ≤ 40%, left atrial dimension >4.0 cm9 or NT-
ProBNP >400 pg/ml if in sinus rhythm or >1200 pg/ml if in atrial fibrillation.10 Patients who 
were unable to understand and comply with the protocol or unable or unwilling to give informed 
consent were not included in the study. The study has ethical approval from the South Yorkshire 
Research Ethics Committee (REC ref: 12/YH/0344) and was conducted in accordance with ICH-
GCP, Declaration of Helsinki, the Data Protection Act 1998 and the NHS Act 2006.  
5 
 
2.1.1. Depression and anxiety  
To assess depression and anxiety we used the Hospital Anxiety and Depression Scale 
(HADS) questionnaire11, consisting of seven questions on depression and seven on anxiety, each 
graded from 0 to 3, giving a total score ranging from 0 to 21 for each emotional state. A score of 
7 or lower, 8 to 10, and 11 or more, implies no, mild or moderate-to-severe depression or 
anxiety.  
2.1.2. Cognitive impairment  
We used the General Practitioner assessment of Cognition (GPCOG), a brief screening 
tool for detecting cognitive impairment.12 The cognitive test includes nine items focusing on time 
orientation, clock drawing, awareness of a current news event and recall of a name and an 
address. Each correct answer scores one point leading to a maximum score of 9. A score of 4 or 
lower indicates cognitive impairment.  
2.1.3. Physical Frailty  
Physical frailty was assessed by asking patients to complete a timed “get up and go” test, 
which asks patients to stand up from a chair, walk a short distance (3 m), turn around, return, and 
sit down again. Less than 10 seconds is normally needed to complete the task, while more than 
20 seconds indicates poor functional independence of the patient.13,14 We defined patients as 
being frail if they were unable to complete the test or took more than 20 sec to complete it. 
Patients were also defined as being frail if they reported difficulties either bathing or dressing 
themselves.  
There are several tools to assess physical frailty which have been extensively validated in 
the literature. There is, however, no consensus on the best performing tool for patients with HF.15 
6 
 
We used the timed “get up and go” test because it is simple, easy to use in routine care, 
correlates well with functional independence and other reliable tools and has been proven to be 
reliable in patients with HF.14,16 
2.1.4. Social Support  
We defined patients to have good social support when they were married, not living alone 
or when they self-reported perceiving good or excellent support from their family.  
2.1.5. Outcomes 
Re-admissions and mortality were automatically recorded in the hospital’s IT system. For 
the present report, the primary outcome of interest was all-cause, unplanned re-admissions or 
mortality within 30-days of discharge. Unplanned re-admission was defined as any type of 
emergency re-admission (including emergency fast-track, admission via the Accident and 
Emergency department, or an urgent admission requested by the GP).  
2.2. Statistical analysis 
We analyzed data from patients who participated in the study between 05/10/2012 and 
15/11/2016 excluding 51 patients who died during the index admission. Recommendations from 
the TRIPOD guidelines were followed for the model development and reporting.17 We compared 
the baseline characteristics of the patients having and not having an event within 30 days of 
discharge. We used chi-squared testing to compare binary or categorical variables between 
groups, and the Kruskal-Wallis test for continuous variables.  
We applied univariable and multivariable logistic regression analysis to relate patient 
characteristics to unplanned re-admission or death within 30 days of discharge. Odds ratios (OR) 
were calculated with 95% confidence intervals (CI). In both analyses, multiple imputation was 
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used to impute missing data. This requires three steps: imputation, analysis and pooling. Each 
missing value was imputed five times following the predictive mean matching method, thus 
producing five imputed data sets; each one of these five imputed data sets was then analysed and 
the results were pooled into one final analysis following Rubin’s method.18,19  
After identifying the most important variables associated with the outcome in the 
univariable analysis (p<0.1), we applied the least absolute shrinkage and selection operator 
(LASSO) technique20 to select the set of predictors for the final multivariable model. LASSO 
uses a cross-validation procedure to select the optimal value for the shrinkage parameter λ. We 
developed and compared a holistic model including both clinical and other measures with a 
reference model based on clinical variables alone.21 Since multiple imputation was applied, we 
repeated all the analyses using a dataset of patients for whom data were complete, and compared 
the results.  
Discrimination refers to the ability to distinguish patients experiencing an event from 
those who did not, and was quantified by the area under the receiver operating characteristic 
curve (AUC). An AUC of 0.5 indicates no discriminative ability at all while an AUC of 1 
indicates perfect discrimination. Multivariable models were internally validated by a bootstrap 
procedure, by sampling with replacement for 200 iterations. For each imputed data set, full 
models were developed in bootstrap samples and evaluated in the original sample to estimate the 
statistical optimism in performance. 22,23  
Besides the composite outcome, we also assessed the model performance when taking 
into account readmission only or death only as an outcome. To evaluate the prediction of 
readmission only we excluded patients who died without being readmitted within 30-days from 
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the analysis dataset. All analyses were conducted using R 3.3.3 statistical software (The R 
Foundation for Statistical Computing, Vienna, Austria).   
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3. Results 
3.1. Baseline characteristics of the study population 
Of the 1145 patients enrolled in the study, 51 died in the hospital and 1094 survived to 
discharge. (Supplementary figure A.1) Median length of hospital-stay during the index 
admission was 10 [6 – 17] days. Of 1094 surviving to discharge, 33 died without being 
readmitted, 27 died after being readmitted and 186 did not die but had an unplanned re-
admission within 30 days. 51% of the unplanned readmissions were related to heart failure, 25% 
to other cardiovascular reasons and 25% to non-cardiovascular problems. (Table 1)  
At admission, 62% of patients were in NYHA functional class III and 30% in class IV. 
Only 41% were in sinus rhythm and only 22% had a Charlson co-morbidity index ≤ 1, while 
30% had a score ≥5. Most patients (86%) were retired and 36% lived alone, 14% had moderate-
to-severe depression, 17% had moderate-to-severe anxiety and 24% reported problems with 
bathing or dressing. Only 36% were willing and able to do a get-up-and-go test, although most 
who did the test managed it in <20 seconds. The median number of tablets prescribed increased 
from 9 to 12 pills per day between admission and discharge.  
 Table 1 
3.2. Univariable analysis 
On univariable analysis (Table 2), patients who were re-admitted or died were on average 
older, had higher daily pill counts, worse NYHA class at admission and discharge, worse renal 
function, and were more likely to have had recent and/or multiple hospitalizations. They were 
also more likely to have evidence of physical frailty, problems with bathing and dressing, 
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moderate-to-severe depression and cognitive impairment. They were less likely to be married 
and more likely to be single.  
 Table 2  
3.3. Multivariable analysis 
In the reference clinical model, the following variables were associated with a worse 
outcome: not being in sinus rhythm, a higher daily pill count, worse NYHA class, dyspnoea at 
rest, higher serum urea and plasma NT-proBNP at discharge, longer length of hospital-stay and 
more emergency hospitalizations in the previous 6 months. Additional predictors included in the 
extended model were: not being married, poor family support and being physically frail. 
 Table 3  
  Data were missing for 20% of the patients for more than one of the variables included in 
this model (Table 3). Analyses using a dataset of 572 patients for whom data were complete 
showed similar results as imputed datasets (supplementary tables B.1 and B.2).  
3.4. Model performance 
The reference clinical model had an area under the curve in ROC analysis of 0.68 [95% 
CI 0.64 – 0.72] in discriminating between patients who did or did not experience the primary 
outcome of all-cause unplanned re-admissions or death within 30 days. The extended model 
including physical frailty and social factors increased the AUC to 0.70 [95% 0.66 – 0.74]. 
Internal validation of the models by bootstrap provided a corrected AUC of 0.66 for the clinical 
model and 0.67 for the extended model, respectively. 
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The extended model for re-admission only or mortality only had AUC of 0.67 and 0.83, 
with internally validated estimates of 0.65 and 0.80, respectively (Table 4). 
 Table 4 
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4. Discussion  
This study demonstrates the high prevalence of diverse aspects of frailty amongst patients 
admitted to hospital with worsening heart failure and their contribution to 30-day outcomes. 
Most clinical trials and registries of patients hospitalized for heart failure collect only clinical 
information thought useful by cardiologists. Only a few have collected data on other aspects of 
patient well-being and very few have investigated the importance of cognitive function or social 
support. Our study suggests that assessing diverse aspects of frailty, physical or social, improves 
prediction of near-term outcomes. However, prediction remains difficult especially for re-
hospitalization. Future analyses will determine whether different aspects of frailty also predict 
longer-term outcomes. 
We found that 1 in 5 patients hospitalized for heart failure will have an unplanned re-
admission and 1 in 20 patients will die within 30 days of discharge. Not all events were related to 
HF and not all would have been preventable, although this was not evaluated for individual 
cases. Clinical trials focusing on treatments to improve cardiac function for patients with 
decompensated heart failure have met with a remarkable lack of success. This failure may be 
because one or more aspects of frailty, which will not respond to short-term pharmacological 
interventions, are key determinants of outcome. Indeed, measures of frailty, in particular physical 
and social, were strongly associated with outcome in our registry. In conventional prognostic 
models, age is usually a strong predictor of outcome, probably because of its association with 
multiple aspects of frailty and co-morbidity rather than merely chronological age. In the present 
multivariable analysis, age was not an independent predictor of outcome perhaps because 
chronological age is just a surrogate measure for frailty.  
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Published prognostic models focusing on clinical variables alone for the prediction of 
short-term outcome have reported relatively poor discrimination, especially for re-
hospitalisation, which is consistent with our findings.5–7 The performance of our model is 
amongst the highest for the composite end-point of all-cause re-hospitalisation or mortality 
within the first few weeks after discharge;7 although the discrimination for re-hospitalisation is 
similar to other published models, we achieved a high discrimination for predicting mortality. 
Our model would be relatively simple to apply to routine care provided information from nursing 
as well as medical records.  
Financial penalties are imposed on hospitals in some countries if a patient is re-admitted 
within 30 days, and therefore models predicting short-term events, especially if they are 
preventable, could be used to improve the quality of care. A high rate of re-admission may 
reflect a poor quality service that simply fails to prevent events. A high rate of re-admission may 
also occur in a high-quality service that only admits patients with advanced disease who cannot 
be managed in the community: such patients are consequently at a high risk of further events. 
Models can be used to compare predicted and actual outcome in different hospitals, taking case-
mix, disease severity and diverse aspects of frailty into account. However, even with our 
extended model, variables shown in previous studies to be related to prognosis were not included 
in our final model. This may reflect inaccurate methods of collecting some data or the inherent 
unpredictability of some events. Our findings confirm prior evidence of the difficulty of 
predicting readmission. Further research is needed to explore the added value of other factors, 
such as evidence of decongestion, early scheduled post-discharge clinical evaluation or therapy 
at discharge. 
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It is important to note that many patients were sufficiently incapacitated that they felt 
unable to undertake tests of physical frailty, complete questionnaires manually or even provide 
consent to participate in a registry. Indicative of that is that only 278 patients in our cohort were 
able or willing to perform the timed “get up and go” test. Accordingly, our study underestimates 
the true burden of frailty amongst patients admitted to hospital with heart failure, which might 
only be properly assessed by clinical audits that do not require individual patient consent.  
Physical frailty will be influenced by the severity of heart failure, co-morbidities and pre-
morbid lifestyle and strongly associated with age. An extreme form of frailty is cardiac cachexia, 
leading to a loss of both fat and muscle mass.24 Studies consistently show that patients with heart 
failure who have a high BMI (in the range of 30 to 35) have a better prognosis,25 although 
whether this reflects milder cardiac disease or is actually protective is controversial. There is a 
growing interest in both sarcopaenia and physical frailty as therapeutic targets.26 Studies of 
exercise training have suggested improvements in quality of life but no clear reduction in 
hospitalization or mortality.27 Studies of anabolic agents have been of modest size and clinical 
benefit is again uncertain.28  
Poor social support may be considered another aspect of frailty.29 A patient receiving 
support from their family may be less likely to be admitted to hospital. Strong social bonds may 
also be an important motivation for self-help. They provide a network that reinforces advice on 
life-style and medication adherence and ensure that patients are well nourished. Companionship 
itself might improve prognosis, giving patients “something to live for”.30 
Two other aspects of frailty can be emotional frailty (anxiety or depression) or mental 
(cognitive dysfunction). Our univariable results suggest that depression and cognitive 
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dysfunction should not be overlooked either. Several studies suggest a strong link between 
depression, functional status31 and outcome.32,33 Many patients with heart failure appear to 
recover from depression if their condition is stabilized, suggesting it might often be a reaction to 
‘bad news’, while antidepressants have not yet been shown to reduce re-hospitalization or 
death.28 Mental frailty, in other words cognitive dysfunction, is a growing concern amongst older 
patients and therefore it is no surprise that it should be common in patients with heart failure.34 
There are many reasons why cognitive dysfunction should be associated with a worse outcome. 
It is associated with older age, co-morbidity and physical frailty.  
 
 Study limitations 
One important limitation of our model is missing data. We addressed this by using 
multiple imputation and confirmed the robustness of our approach by repeating the analysis only 
on un-imputed data, which gave similar results. Another limitation is that the model was only 
internally validated. Further external validation for other hospitals in the UK and in other 
countries with different provision and organization of health-care is required. Some of our data-
collection methods, for instance the HADS questionnaire, have been developed primarily for 
research and have not been extensively tested in routine practice for patients with heart failure. 
Questionnaires were only administered once; changes are likely to have occurred during or after 
hospitalization. Physical frailty was assessed by the timed “get up and go” test and by reported 
difficulties in bathing and dressing. These describe functional status and disability, which are 
part of a broader conception of “frailty”, which, however, does include other elements, such as 
mental frailty.35 The limited number of patients willing or able to perform the get up and go test 
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limits the wider applicability of the frailty test. Finally, we restricted our analysis to 30 day 
outcome, while longer term patterns are also relevant.  
 
Conclusions 
Measures of frailty and social support improve the prediction of 30-day unplanned 
readmission or death to a modest extent compared to models including only conventional clinical 
risk predictors. However, prediction of events in the short-term, especially re-hospitalisation, 
remains difficult. Which aspects of frailty are most important and whether interventions to 
reduce frailty can improve outcome, requires more research.  
17 
 
Funding and Conflict of interest  
I. Sokoreli, G. J. de Vries, S. Pauws, and J. Riistama are employed by Philips Research. J. 
Cleland, A. Clark, K. Dobbs, J. Bulemfu have received departmental research support from 
Philips. E. Steyerberg has no conflict of interest to declare.  
  
18 
 
References 
1.  Stewart S, Blue L. Improving Outcomes in Chronic Heart Failure. Stewart S, Blue L, eds. 
London, UK; 2001.  
2.  Dunlay SM, Redfield MM, Weston SA, Therneau TM, Hall Long K, Shah ND, Roger VL. 
Hospitalizations After Heart Failure Diagnosis. A Community Perspective. J Am Coll 
Cardiol 2009;54:1695–1702.  
3.  Nair A. Anticoagulation in patients with heart failure: who, when, and why? Eur Hear J 
Suppl 2006;8:E32–E38.  
4.  Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson 
PA, Strömberg A, Veldhuisen DJ van, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen 
M, Priori SG, Swedberg K, Vahanian A, Camm J, Caterina R De, Dean V, Dickstein K, 
Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, 
Silber S, Tendera M, Widimsky P, Zamorano JL, et al. ESC Guidelines for the diagnosis 
and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis 
and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of 
Cardiology. Developed in collaboration with the Heart. Eur J Heart Fail 2008;10:933–
989.  
5.  Ross JS, Mulvey GK, Stauffer B, Patlolla V, Bernheim SM, Keenan PS, Krumholz HM. 
Statistical Models and Patient Predictors of Readmission for Heart Failure: A Systematic 
Review. Arch Intern Med American Medical Association; 2008;168:1371.  
6.  Kansagara D, Englander H, Salanitro A, Kagen D, Theobald C, Freeman M, Kripalani S. 
Risk prediction models for hospital readmission: A systematic review. JAMA - J Am Med 
19 
 
Assoc American Medical Association; 2011;306:1688–1698.  
7.  Rahimi K, Bennett D, Conrad N, Williams TM, Basu J, Dwight J, Woodward M, Patel A, 
McMurray J, MacMahon S. Risk prediction in patients with heart failure: A systematic 
review and analysis. JACC Hear Fail 2014;2:440–446.  
8.  Charlson ME, Pompei P, Ales KL, MacKenzie CR, MacKenzie R. A new method of 
classifying prognostic in longitudinal studies: development and validation. J Chronic Dis 
1987;40:373–383.  
9.  Nikitin N., Witte KK., Thackray SD., Goodge L., Clark A., Cleland JG. Effect of Age and 
Sex on Left Atrial Morphology and Function. Eur Hear J - Cardiovasc Imaging 
2003;4:36–42.  
10.  Shelton RJ, Clark AL, Goode K, Rigby AS, Cleland JGF. The diagnostic utility of N-
terminal pro-B-type natriuretic peptide for the detection of major structural heart disease 
in patients with atrial fibrillation. Eur Heart J 2006;27:2353–2361.  
11.  Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr 
Scand 1983;67:361–370.  
12.  Brodaty H, Kemp NM, Low LF. Characteristics of the GPCOG, a screening tool for 
cognitive impairment. Int J Geriatr Psychiatry 2004;19:870–874.  
13.  Mathias, S., Nayak, U.S., Isaacs B. Balance in elderly patients: the ‘get up and go’ test. 
Arch Phys Med Rehabil 1986;67:387–389.  
14.  Podsiadlo D, Richardson S. The Timed “Up & Go”: A Test of Basic Functional Mobility 
for Frail Elderly Persons. J Am Geriatr Soc 1991;39:142–148.  
20 
 
15.  McDonagh J, Martin L, Ferguson C, Jha SR, Macdonald PS, Davidson PM, Newton PJ. 
Frailty assessment instruments in heart failure: A systematic review. Eur. J. Cardiovasc. 
Nurs. 2018. p. 23–35.  
16.  Hwang R, Morris NR, Mandrusiak A, Mudge A, Suna J, Adsett J, Russell T. Timed Up 
and Go Test: A Reliable and Valid Test in Patients With Chronic Heart Failure. J Card 
Fail 2016;22:646–650.  
17.  Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a 
multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The 
TRIPOD Statement. Eur Urol 2015;67:1142–1151.  
18.  Buuren S van. Flexible Imputation of Missing Data. CRC Press; 2012.  
19.  Rubin DB. Multiple Imputation for Nonresponse in Surveys. John Wiley & Sons; 1987.  
20.  Tibshirani R. Regression shrinkage and selection via the lasso: A retrospective. J R Stat 
Soc Ser B Stat Methodol 2011;73:273–282.  
21.  Steyerberg EW, Pencina MJ, Lingsma HF, Kattan MW, Vickers AJ, Calster B van. 
Assessing the incremental value of diagnostic and prognostic markers: A review and 
illustration. Eur J Clin Invest Blackwell Publishing Ltd; 2012;42:216–228.  
22.  Harrel F. Regression modeling strategies: with applications to linear models, logistic and 
ordinal regression, and survival analysis. 2015.  
23.  Steyerberg EW. Clinical prediction models : a practical approach to development, 
validation, and updating. Stat. Biol. Heal. Springer; 2009.  
24.  Lavie CJ, Schutter A De, Alpert MA, Mehra MR, Milani R V, Ventura HO. Obesity 
21 
 
paradox, cachexia, frailty, and heart failure. Heart Fail Clin Elsevier; 2014;10:319–326.  
25.  Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay 
EL, Sokol SI, Bader F, Krumholz HM. The Obesity Paradox. Arch Intern Med 
2005;165:55.  
26.  Springer J, Springer J-I, Anker SD. Muscle wasting and sarcopenia in heart failure and 
beyond: update 2017. ESC Hear Fail Wiley-Blackwell; 2017;4:492–498.  
27.  Davies EJ, Moxham T, Rees K, Singh S, Coats AJS, Ebrahim S, Lough F, Taylor RS. 
Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis. 
Eur J Heart Fail 2010;12:706–715.  
28.  Toma M, McAlister FA, Coglianese EE, Vidi V, Vasaiwala S, Bakal JA, Armstrong PW, 
Ezekowitz JA. Testosterone Supplementation in Heart Failure: A Meta-Analysis. Circ 
Hear Fail 2012;5:315–321.  
29.  Bunt S, Steverink N, Olthof J, Schans CP van der, Hobbelen JSM. Social frailty in older 
adults: a scoping review. Eur J Ageing Springer Netherlands; 2017;14:323–334.  
30.  Filipovic M, Jeger R V, Girard T, Probst C, Pfisterer M, Gürke L, Studer W, Seeberger 
MD. Predictors of long-term mortality and cardiac events in patients with known or 
suspected coronary artery disease who survive major non-cardiac surgery. Anaesthesia 
Department of Anaesthesia, University Hospital Basel, CH 4031 Basel, Switzerland. 
mfilipovic@uhbs.ch: Wiley-Blackwell; 2005;60:5–11.  
31.  Saleh ZT, Wu J-R, Salami I, Yousef K, Lennie TA. The Association Between Depressive 
Symptoms and N-Terminal Pro–B-Type Natriuretic Peptide With Functional Status in 
Patients With Heart Failure. J Cardiovasc Nurs 2018;1.  
22 
 
32.  Sokoreli I, Vries JJG de, Pauws SC, Steyerberg EW. Depression and anxiety as predictors 
of mortality among heart failure patients: systematic review and meta-analysis. Heart Fail 
Rev 2016;21:49–63.  
33.  Sokoreli I, Vries JJG de, Riistama JM, Pauws SC, Steyerberg EW, Tesanovic A, Geleijnse 
G, Goode KM, Crundall-Goode A, Kazmi S, Cleland JG, Clark AL. Depression as an 
independent prognostic factor for all-cause mortality after a hospital admission for 
worsening heart failure. Int J Cardiol 2016;220:202–207.  
34.  Wolters FJ, Segufa RA, Darweesh SKL, Bos D, Ikram MA, Sabayan B, Hofman A, 
Sedaghat S. Coronary heart disease, heart failure, and the risk of dementia: A systematic 
review and meta-analysis. Alzheimer’s Dement 2018;  
35.  Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the Concepts of 
Disability, Frailty, and Comorbidity: Implications for Improved Targeting and Care. 
Journals Gerontol Ser A Biol Sci Med Sci Oxford University Press; 2004;59:M255–M263.  
  
23 
 
Figure legends 
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Tables 
Table 1 Baseline characteristics and outcomes of the study cohort (N = 1094). Characteristics are summarized 
by their count and fraction (N (%)) for categorical or their median and interquartile range (Median [25th – 
75th]) for continuous variables, respectively. 
 All 
 
 
(N = 1094) 
Re-admitted  
or died within 
30 days  
(N = 246) 
No events 
within 30 
days  
(N = 848) 
Compare 
w/ and w/o 
events 
Characteristics Valid N Summary Summary Summary P-value* 
Demographics 
Age, years 1094 77 [68 – 83] 79 [72 – 85] 76 [67 – 82] <0.001 
Women, % 1094 433 (40%) 100 (41%) 333 (39%) 0.75 
Vital signs at hospital admission and other measurements 
Heart Rate, BPM 1067 88 [72 – 108] 84 [70 – 106] 89 [73 – 108] <0.1 
Systolic Blood Pressure, mmHg 1083 129 [115–146] 125 [112 – 144] 130 [115 – 146] <0.05 
Diastolic Blood Pressure, mmHg 1083 75 [63 – 86] 70 [60 – 82] 76 [64 – 87] <0.001 
Sinus Rhythm, % 1088 446 (41%) 84 (35%) 362 (43%) <0.05 
Weight, kg 987 82 [69 – 97] 79 [69 – 94] 82 [69 – 99] 0.19 
BMI, kg/m2 806 29 [25 – 34] 29 [25 – 34] 29 [25 – 34] 0.53 
Medication at admission 
Total pill count 969 9 [5 – 13] 10 [6 - 14] 8 [5 – 12] <0.01 
HF related symptoms at admission 
NYHA(**): Class I or II, % 
NYHA(**): Class III, % 
NYHA(**): Class IV, % 
1052 81 (8%) 
651 (62%) 
320 (30%) 
16 (7%) 
126 (54%) 
91 (39%) 
65 (8%) 
525 (64%) 
229 (28%) 
<0.01 
Co-morbidities  
CCI score: 
-≤ 1, % 
-2, % 
-3, % 
-4, % 
-≥5, % 
1094  
235 (22%) 
199 (18%) 
187 (17%) 
149 (14%) 
324 (30%) 
 
53 (22%) 
36 (15%) 
40 (16%) 
30 (12%) 
87 (35%) 
 
182 (22%) 
163 (19%) 
147 (17%) 
119 (14%) 
237 (28%) 
0.15 
Diabetes, % 1094 380 (39%) 74 (35%) 306 (40%) 0.27 
COPD, % 1094 188 (17%) 49 (20%) 139 (16%) 0.23 
HF symptoms and vital signs at discharge 
Length of stay, days 1094 10 [6 - 17] 12 [7 – 21] 10 [6 – 16] <0.01 
Weight, kg 693 77 [65 – 91] 75 [64 – 88] 78 [66 – 92] 0.13 
NYHA: Class I or II, % 
NYHA: Class III, % 
NYHA: Class IV, % 
907 743 (82%) 
143 (16%) 
21 (2%) 
134 (71%) 
45 (24%) 
10 (5%) 
609 (85%) 
98 (14%) 
11 (2%) 
<0.001 
Dyspnoea at rest, % 932 60 (6%) 22 (11%) 38 (5%) <0.001 
Left ventricular systolic dysfunction 
-None-trivial 
-Mild-to-moderate 
-Moderate-to-severe 
920  
254 (28%) 
154 (17%) 
512 (56%) 
 
193 (27%) 
27 (14%) 
111 (56%) 
 
61 (31%) 
127 (18%) 
401 (56%) 
0.30 
Lab values at discharge 
NT-proBNP, pg/mL 905 4468  6121 4100  <0.01 
25 
 
[1895 –9889]  [2013 -12110] [1832 – 9210] 
Urea, mmol/l 1087 9 [7 – 14] 11 [8 – 16] 9 [6 – 13] <0.001 
Creatinine, micromol/l 1085 105 [83 – 140] 119 [91 – 156] 102 [82 – 136] <0.001 
Medication at discharge 
Total daily pill count 1044 12 [9 -16] 12 [9 -17] 12 [9 – 16] <0.05 
Prior hospitalization 
≥ 2 EM in prior 6 month, % 1094 143 (13%) 46 (19%) 97 (11%) <0.01 
≥ 1 EM in prior 1 month, % 1094 189 (17%) 61 (25%) 128 (15%) <0.001 
Social status/support 
Reported good or excellent support 
from family, % 
1094 451 (41%) 87 (35%) 364 (43%) <0.05 
Living alone, % 962 349 (36%) 83 (41%) 266 (35%) 0.16 
Married, % 1094 531 (49%) 102 (42%) 429 (51%) <0.05 
Retired, % 912 783 (86%) 176 (92%) 607 (84%) <0.01 
Mood and cognitive function 
Depression, HADS 
-None, % 
-Mild, % 
-Moderate-to-severe, % 
391  
257 (66%) 
78 (20%) 
56 (14%) 
 
43 (61%) 
11 (16%) 
17 (24%) 
 
214 (67%) 
67 (21%) 
39 (12%) 
<0.05 
Anxiety, HADS 
-None, % 
-Mild, % 
-Moderate-to-severe, % 
384  
232 (60%) 
87 (23%) 
65 (17%) 
 
44 (64%) 
13 (19%) 
12 (17%) 
 
188 (60%) 
74 (24%) 
53 (17%) 
0.70 
GPCOG score ≤ 4, % 399 29 (7%) 8 (10%) 21 (7%) 0.44 
Frailty and mobility 
Get up and go test: 
-willing and able to complete, % 
-not willing to try, % 
- not able due to HF, % 
- other reasons, % 
781  
284 (36%) 
40 (5%) 
6 (1%) 
451 (58%) 
 
52 (32%) 
11 (7%) 
2 (1%) 
181 (74%) 
 
232 (38%) 
29 (5%) 
4 (1%) 
583 (67%) 
0.50 
Time for get up and go test, sec 278 9 [6 - 15] 12 [8 – 20] 8 [6 – 14] <0.01 
Get up and go test in < 20 sec  278 233 (84%) 41 (80%) 192 (85%) 0.60 
Having trouble bathing or dressing,% 879 213 (24%) 57 (31%) 156 (23%) <0.05 
Outcomes 
30-day unplanned re-admission, % 1094 213 (19%) - - - 
30-day CV unplanned re-admission, 
% 
1094 163 (15%) - - - 
30-day HF unplanned re-admission, 
% 
1094 109 (10%) - - - 
30-day mortality, % 1094 60 (5%)    
NYHA, New York Heart Association; CCI, Charlson Co-morbidity Index, HADS, Hospital Anxiety and Depression Scale; 
GPCOG, General Practitioner assessment of Cognition. 
(*) 0.1 level of significance 
(**) worst during the last 7-days 
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Table 2 Univariable analysis of the imputed dataset (all subjects included using multiple imputation) for 30-
day unplanned re-admission or mortality. 
 Number of imputed 
data points 
OR 95% CI 
Age, years (*) 0 1.21 1.07 – 1.37 
Women, yes 0 1.06 0.79 – 1.41 
Heart Rate at admission, BPM (*) 27 0.95 0.90 – 1.00 
Systolic BP at admission, mmHg (*) 11 0.94 0.88 – 0.99 
Diastolic BP at admission, mmHg (*) 11 0.84 0.77 – 0.91 
Weight at admission, kg  107 0.99 0.99 – 1.00 
BMI at admission, kg/m2 288 0.99 0.97 – 1.01 
Sinus Rhythm at admission, yes 6 0.70 0.52 – 0.94 
Total pill count at admission 125 1.05 1.02 – 1.07 
NYHA Class IV at admission, yes (**) 42 1.70 1.26 – 2.28 
CCI, score 0 1.04 0.98 – 1.10 
Diabetes, yes 0 0.79 0.58 – 1.07 
COPD, yes 0 1.27 0.88 – 1.81 
Length of stay, (*) 0 1.15 1.04 – 1.27 
Weight at discharge, kg  401 0.99 0.99 – 1.00 
NYHA class III/IV at discharge, yes 187 2.44 1.76 – 3.37 
Dyspnoea at rest at discharge, yes 162 2.97 1.83 – 4.80 
Moderate-to-severe left ventricular systolic dysfunction, yes 174 1.01 0.73 – 1.38 
NT-proBNP at discharge pg/mL (log) 189 1.22 1.08 – 1.37 
Urea at discharge, mmol/l (log) 7 1.99 1.54 – 2.58 
Creatinine at discharge, micromol/l (log) 9 1.93 1.37 – 2.72 
Total daily pill count at discharge 50 1.03 1.01 – 1.05 
Number of prior EM hospitalizations in 6 months 0 1.36 1.19 – 1.56 
Prior EM in 1 month, yes 0 1.85 1.31 – 2.61 
Reported good or excellent support from family, yes 0 0.73 0.54 – 0.97 
Living alone, yes 132 1.36 1.02 – 1.82 
Married, yes 0 0.69 0.52 – 0.92 
Retired, yes 182 1.43 0.95 – 2.24 
Depression, HADS 
- None-to-mild, yes 
- Moderate-to-severe, yes 
703  
1 
1.65 
 
- 
1.13 – 2.39 
Anxiety, HADS 
- None-to-mild, yes 
- Moderate-to-severe, yes 
710  
1 
1.18 
 
- 
0.81 – 1.70 
Cognitive impairment GPCOG score ≤ 4, yes 695 1.83 1.18 – 2.80 
Physical frailty, yes 249 1.77 1.13 – 2.88 
NYHA, New York Heart Association; CCI, Charlson co-morbidity index, EM, emergency; HADS, Hospital Anxiety and 
Depression Scale; GPCOG, General Practitioner assessment of Cognition. 
(*)10 unit increase 
(**) worst during the last 7-days 
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Table 3 Multivariable models predicting 30-day unplanned re-admission or mortality in 1094 patients; 
reference model includes clinical characteristics; extended model adds physical frailty and social predictors.  
 Imputed 
data 
Reference model Extended model  
Variables N OR (95% CI) OR (95% CI) 
Number of daily pills at admission 125 1.03 (1.00 – 1.06) 1.03 (1.00 – 1.06) 
Sinus rhythm 6 0.77 (0.56 – 1.05) 0.77 (0.57 – 1.06) 
Urea, mmol/l (log) at discharge 7 1.57 (1.19 – 2.07) 1.61 (1.22 – 2.13) 
NT-proBNP pg/mL (log) at discharge 189 1.09 (0.96 – 1.24) 1.07 (0.94 – 1.21) 
NYHA class at discharge, 1-class 
increase 
187 1.47 (1.14 – 1.90) 1.40 (1.08 – 1.82) 
Dyspnoea at rest at discharge 161 1.50 (0.86 – 2.63) 1.72 (0.98 – 3.04) 
Length of stay (10-day increase) 0 1.08 (0.97 – 1.19)  1.07 (0.96 – 1.20) 
Number of prior EM hospitalizations in 
6months 
0 1.27 (1.10 – 1.45) 1.26 (1.10 – 1.45) 
Physical frailty 250  1.21 (0.73 – 2.00) 
Married  0  0.72 (0.53 – 0.97) 
Reported good or excellent support from 
family 
0  0.74 (0.53 – 1.02) 
AUC [95% CI] 
(Bootstrap optimism-corrected AUC) 
 
0.68 [0.64 – 0.72] 
(0.66) 
0.70 [0.66 – 0.74] 
(0.67) 
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Table 4 Discrimination of reference clinical models and extended models for composite and single 
outcomes among HF patients; reported as AUC [95% CI] (Bootstrap optimism-corrected AUC).  
 30-day composite outcome 30-day unplanned 
re-admission 
30-day mortality 
Reference 
model 
0.68 [95% CI 0.64 – 0.72] 
(0.66) 
0.65 [0.61 – 0.69]  
(0.63) 
0.81 [0.76 – 0.87] 
(0.79) 
Extended 
model  
0.70 [95% CI 0.66 – 0.74] 
(0.67) 
0.67 [0.63 – 0.71] 
 (0.65) 
0.83 [0.77 – 0.88] 
(0.80) 
Incremental 
p-value <0.05 <0.05 0.27 
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Appendices 
 
A TRIPOD diagram 
 
 
Figure A.1 TRIPOD diagram 
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B Complete cases analysis 
 
Table B.1 Univariable analysis of original dataset (complete cases analysis) for 30 day unplanned re-admission 
or mortality. 
Only subjects with available data 
 Valid N OR 95% CI 
Age, years (*) 1094 1.21 1.07 – 1.37 
Women, yes 1094 1.06 0.79 – 1.41 
Heart Rate at admission, BPM (*) 1067 0.95 0.90 – 1.00 
Systolic BP at admission, mmHg (*) 1083 0.94 0.89 – 1.00 
Diastolic BP at admission, mmHg (*) 1083 0.83 0.76 – 0.91 
Weight at admission, kg  987 0.99 0.99 – 1.00 
BMI at admission, kg/m2 806 0.99 0.97 – 1.01 
Sinus Rhythm at admission, yes 1088 0.71 0.53 – 0.95 
Total pill count at admission 969 1.04 1.02 – 1.07 
NYHA at admission: Class IV, yes (**) 1052 1.65 1.22 – 2.24 
CCI, score 1094 1.04 0.98 – 1.10 
Diabetes, yes 1094 0.78 0.57 – 1.06 
COPD, yes 1094 1.27 0.88 – 1.81 
Length of stay, (*) 1094 1.15 1.04 – 1.27 
Weight at discharge, kg  693 0.99 0.98 – 1.00 
NYHA class III/IV at discharge, yes 907 2.29 1.57 – 3.32 
Dyspnoea at rest at discharge, yes 932 2.37 1.35 – 4.08 
Moderate-to-severe left ventricular systolic dysfunction, yes 920 1.01 0.73 – 1.38 
NT-proBNP at discharge pg/mL (log) 905 1.20 1.05 – 1.37 
Urea at discharge, mmol/l (log) 1087 1.96 1.51 – 2.55 
Creatinine at discharge, micromol/l (log) 1085 1.95 1.38 – 2.75 
Total daily pill count at discharge 1044 1.03 1.01 – 1.05 
Prior EM in 1 month 1094 1.85 1.31 – 2.61 
Number of prior EM hospitalizations in 6months 1094 1.36 1.19 – 1.56 
Reported good or excellent support from family, yes 1094 0.73 0.54 – 0.97 
Living alone, yes 962 1.27 0.92 – 1.74 
Married, yes 1094 0.69 0.52 – 0.92 
Retired, yes 912 2.20 1.29 – 4.02 
Depression, HADS 
- None-to-mild, yes 
- Moderate-to-severe, yes 
391  
1 
2.27 
 
- 
1.17– 4.25 
Anxiety, HADS 
- None-to-mild, yes 
- Moderate-to-severe, yes 
384  
1 
1.04 
 
- 
0.50 – 2.02 
Cognitive impairment GPCOG score ≤ 4, yes 399 1.55 0.62 – 3.52 
Physical frailty, yes 845 2.05 1.21 – 3.69 
NYHA, New York Heart Association; CCI, Charlson Co-morbidity Index, HADS, Hospital Anxiety and Depression Scale; 
GPCOG, General Practitioner assessment of Cognition. 
(*)10 unit decrease 
(**) worst during the last 7-days 
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Table B.2 Multivariable models developed on n=572 complete cases predicting 30-day unplanned re-
admission or mortality; reference model includes clinical characteristics; extended model adds physical frailty 
and social predictors. 
 Reference model Extended model 
Variables OR (95% CI) OR (95% CI) 
Number of daily pills at admission 1.04 (1.00 – 1.07) 1.04 (1.00 – 1.08) 
Sinus rhythm 0.64 (0.41 – 0.99) 0.63 (0.40 – 0.98) 
Urea, mmol/l (log) at discharge 1.63 (1.10 – 2.42) 1.61 (1.08 – 2.40) 
NT-proBNP pg/mL (log) at discharge 0.97 (0.81 – 1.16) 0.95 (0.80 – 1.14) 
NYHA class at discharge, 1-class increase 1.45 (1.01 – 2.42) 1.39 (0.96 – 2.01) 
Dyspnoea at rest at discharge 2.06 (0.99 – 4.29) 2.27 (1.07 – 4.81) 
Length of stay (10-day increase) 1.04 (0.88 – 1. 23) 1.03 (0.86 – 1. 23) 
Prior EM hospitalizations in 6months 1.28 (1.07 – 1.53) 1.26 (1.05 – 1.51) 
Physical frailty  1.37 (0.69 – 2.69) 
Married   0.64 (0.41 – 0.99) 
Reported good or excellent support from family   0.92 (0.59 – 1.43) 
AUC [95% CI] 
(Bootstrap optimism-corrected AUC) 
0.69 (0.67) 0.71 (0.68) 
 
 
